This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Nick Saban has strong reaction ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...

India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...

In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

Sana is Incorporating its Fusogen Technology to Develop SG293, a CD8-targeted Fusosome that Makes CD19-directed CAR T Cells in vivo; Expects to File IND for SG293 in B-cell Cancers and/or B-cell ...

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

WindRose Health Investors, LLC ("WindRose"), a New York-based healthcare private equity firm, today announced that it has made a strategic investment in Stellus Rx ("Stellus Rx" or the "Company"), a ...

O, Inc., the pioneer in natural language computing, today announced a decisive legal victory against IO Products, Inc., OpenAI, Sam Altman, and Jony Ive. The United States Court of Appeals for the ...

Cholesterol meds—taking by millions of Americans every day—often come with a lifelong prescription, adding out-of-pocket ...